FDA Panel Backs Expanded Access for 6 Peptides

A U.S. Food and Drug Administration panel has recommended expanding access to six peptides, potentially opening new treatment options for patients. The decision reflects growing interest in peptide-based therapies and their medical applications. Peptides are short chains of amino acids with potential therapeutic benefits for various health conditions. The FDA panel's recommendation could accelerate availability of these treatments to broader patient populations.